PBLA PBLA

Panbela Therapeutics Stock Price

0.30
-0.059 (-16.43%)
Upgrade to Real-Time
Regular Market
0.30
Volume 1,343,004
Bid Price 0.2718
Ask Price 0.30
News (2)
Day High 0.3012

Low
0.2028

52 Week Range

High
2.56

Day Low 0.2501
Company Name Stock Ticker Symbol Market Type
Panbela Therapeutics Inc PBLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.059 -16.43% 0.30 12:07:38
Open Price Low Price High Price Close Price Prev Close
0.2501 0.2501 0.3012 0.359
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
691 1,343,004 $ 0.2663491 $ 357,708 - 0.2028 - 2.56
Last Trade Time Type Quantity Stock Price Currency
12:07:38 100 $ 0.30 USD

Period:

Draw Mode:

Panbela Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.23M 20.77M 19.69M $ - $ - -0.89 -0.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 9.90%

more financials information »

Panbela Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PBLA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.30470.53080.25010.3403851,599,730-0.0047-1.54%
1 Month0.660.99760.20280.45219481,796,224-0.36-54.55%
3 Months0.971.420.20280.4710739597,555-0.67-69.07%
6 Months2.082.190.20280.5136644298,996-1.78-85.58%
1 Year2.162.560.20280.7089687174,821-1.86-86.11%
3 Years3.408.800.20282.11167,675-3.10-91.18%
5 Years3.408.800.20282.11167,675-3.10-91.18%

Panbela Therapeutics Description

Panbela Therapeutics Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed a polyamine analogue compound referred as SBP-101 for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications.


Your Recent History
NASDAQ
PBLA
Panbela Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now